Quick Answer
INTEGRATED BIOPHARMA INC reported Stockholders Equity of $20.32 million for fiscal year 2025.
INTEGRATED BIOPHARMA INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $20.32M | +5.6% |
| 2024 | $19.24M | +2.0% |
| 2023 | $18.86M | +1.5% |
| 2022 | $18.57M | +29.6% |
| 2021 | $14.33M | +136.3% |
| 2020 | $6.07M | +220.5% |
| 2019 | $1.89M | +136.2% |
| 2018 | -$5.24M | +11.7% |
| 2017 | -$5.93M | +28.8% |
| 2016 | -$8.33M | +10.6% |
| 2015 | -$9.32M | +8.3% |
| 2014 | -$10.15M | +1.3% |
| 2013 | -$10.29M | +0.9% |
| 2012 | -$10.38M | -34.9% |
| 2011 | -$7.70M | -35.1% |
| 2010 | -$5.70M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $19.77M | +0.2% | -3.5% |
| September 30, 2025 | $20.49M | +10.5% | +0.8% |
| June 30, 2025 | $20.32M | +5.6% | -0.3% |
| March 31, 2025 | $20.38M | +7.8% | +3.3% |
| December 31, 2024 | $19.73M | +6.3% | +6.3% |
| September 30, 2024 | $18.55M | -1.8% | -3.6% |
| June 30, 2024 | $19.24M | +2.0% | +1.7% |
| March 31, 2024 | $18.91M | +100807.1% | +1.9% |
- INTEGRATED BIOPHARMA INC showed an increase of +5.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, INTEGRATED BIOPHARMA INC’s stockholders equity has grown by 456.7% (from -$5.70 million to $20.32 million).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: